← Back to Search
Behavioural Intervention
CuidaTEXT for Alzheimer's Disease (CuidaTEXT R01 Trial)
Fairway, KS
N/A
Recruiting
Led By Jaime Perales Puchalt, PhD, MPH
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test the effectiveness of a text messaging intervention called CuidaTEXT for Latino caregivers of individuals with Alzheimer's disease and Related Dementias (ADRD). Participants will receive different types of text
See full description
Who is the study for?
This trial is for Latino caregivers over 18 years old who are providing hands-on care to a relative diagnosed with Alzheimer's or related dementia, indicated by an AD-8 score ≥2. Participants must have some depressive symptoms (CESD-10 score ≥7), be able to read and write, use text messaging weekly on their own cell phone, and speak Spanish or English.
What is being tested?
The study tests CuidaTEXT, a text message-based support intervention for Latino caregivers of Alzheimer's patients. It aims to see if this approach can reduce caregiver stress and its negative effects by sending educational texts about dementia care, social support messages, self-care tips, and guidance on managing behavioral symptoms.See study design
What are the potential side effects?
Since the intervention involves receiving informational and supportive text messages rather than medical treatment or drugs, there are no direct physical side effects expected from participating in this trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in caregiver depressive symptoms
Secondary study objectives
Change in caregiver behavioral distress symptoms
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CuidaTEXTExperimental Treatment1 Intervention
6 months of CuidaTEXT intervention + 1-month post-treatment
Group II: 7-Month Waitlist ControlActive Control1 Intervention
Participants allocated to this arm will be offered the opportunity to start CuidaTEXT immediately after their 7 Month follow-up assessment
Find a Location
Closest Location:University of Kansas Medical Center· Fairway, KS· 195 miles
Who is running the clinical trial?
University of Kansas Medical CenterLead Sponsor
522 Previous Clinical Trials
177,498 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,835 Previous Clinical Trials
28,184,262 Total Patients Enrolled
University of Puerto RicoOTHER
68 Previous Clinical Trials
22,040 Total Patients Enrolled
Icahn School of Medicine at Mount SinaiOTHER
929 Previous Clinical Trials
578,574 Total Patients Enrolled
University of MiamiOTHER
974 Previous Clinical Trials
423,077 Total Patients Enrolled
Jaime Perales Puchalt, PhD, MPHPrincipal InvestigatorUniversity of Kansas Medical Center
1 Previous Clinical Trials
243 Total Patients Enrolled